{"acute myeloid leukaemia": 101.76, "acute myeloid leukaemia recurrent": 125.5, "adverse event": 2.4, "agranulocytosis": 8.54, "anaemia": 4.23, "autoimmune haemolytic anaemia": 37.02, "blood calcium decreased": 9.84, "blood creatinine increased": 2.05, "blood lactate dehydrogenase increased": 9.92, "blood phosphorus increased": 97.22, "blood potassium increased": 9.31, "blood uric acid increased": 9.97, "bone marrow failure": 6.41, "bone marrow transplant": 42.67, "c-reactive protein increased": 2.4, "chronic lymphocytic leukaemia": 157.86, "chronic lymphocytic leukaemia recurrent": 119.35, "cytopenia": 62.61, "disease progression": 3.38, "dysphagia": 2.28, "febrile neutropenia": 27.58, "fungal infection": 5.33, "general physical health deterioration": 2.31, "haematotoxicity": 29.87, "haemoglobin decreased": 3.66, "haemolysis": 6.25, "haemolytic anaemia": 4.14, "hepatic cytolysis": 2.16, "hospitalisation": 2.11, "hypercalcaemia": 6.64, "hyperkalaemia": 2.41, "immune thrombocytopenia": 2.27, "infection": 9.81, "intentional product use issue": 3.1, "laboratory test abnormal": 8.71, "leukocytosis": 4.83, "leukopenia": 4.26, "lymphocyte count decreased": 4.67, "mantle cell lymphoma": 54.56, "minimal residual disease": 266.86, "multiple organ dysfunction syndrome": 3.28, "myelodysplastic syndrome": 9.41, "myelosuppression": 20.9, "neutropenia": 24.04, "neutropenic sepsis": 14.63, "neutrophil count decreased": 6.44, "off label use": 11.06, "pancytopenia": 10.07, "plasma cell myeloma": 14.74, "platelet count decreased": 4.91, "pleural effusion": 2.51, "pneumonia": 3.78, "pneumonia fungal": 21.07, "product use complaint": 30.92, "richter's syndrome": 517.53, "sepsis": 5.9, "septic shock": 5.3, "splenomegaly": 10.96, "systemic mycosis": 140.39, "therapeutic product effect incomplete": 2.65, "thrombocytopenia": 9.58, "transplant": 36.22, "tumour lysis syndrome": 204.4, "unevaluable event": 8.83, "white blood cell count decreased": 3.99, "white blood cell count increased": 4.51}